Lose weight by eating less salt! - Go on! - Try it! - You will feel so much better!
See my website
Wilde About Steroids

Read my Mensa article on Obesity and the Salt Connection

Read my Mensa article on Cruelty, Negligence and the Abuse of Power in the NHS: Fighting the System

Read about the cruel treatment I suffered at the Sheffield Dental Hospital: Long In The Toothache

You can contact me by email from my website. The site does not sell anything and has no banners, sponsors or adverts - just helpful information about how salt can cause obesity.

Showing posts with label Aricept. Show all posts
Showing posts with label Aricept. Show all posts

Tuesday, 4 December 2007

Alzheimer drugs don't delay dementia onset - study

Article on Reuters - Alzheimer drugs don't delay dementia onset -study

Extract:

"LONDON, Nov 27 (Reuters) - Giving Alzheimer's drugs to people with early memory problems does not seem to delay the onset of the disease, researchers said on Tuesday.

Three main drugs -- Aricept, or donepezil; Exelon, or rivastigmine; and Reminyl, or galantamine -- are currently approved for use in mild-to-moderate Alzheimer's disease.

They are also often prescribed on a so-called "off-label" basis to people with pre-dementia."

Saturday, 30 June 2007

Aricept is to be available on the NHS

Alzheimer's drugs to be available on NHS - Telegraph

Extract:

"Victims of a mild form of Alzheimer's disease are to be given access to anti-dementia drugs on the NHS.

Campaigners yesterday hailed the "dramatic concession", which came after a five-day legal hearing.


The National Institute for Health and Clinical Excellence (Nice) triggered a High Court action when it decided the drugs were not cost effective in relation to the benefits they offered to sufferers in the early stages of the disease.

Yesterday a QC for Nice, which is responsible for providing national guidance on treatments available on the NHS, clarified the official position of the watchdog.

Nigel Giffin QC said doctors did have discretion, in certain circumstances, to prescribe the drugs to patients with mild symptoms. The statement came after Mrs Justice Dobbs, sitting in London, had closely questioned Mr Giffin on the issue before she reserved judgment on the case.

Mr Giffin said there were circumstances in which doctors, provided they took into account the Nice guidance, could exercise clinical judgment and decide that an individual patient was entitled to the drugs."

Obesity is the biggest avoidable factor in developing Alzheimer's disease, and obesity is caused by fluid retention/salt sensitivity, so you can reduce your risk of developing Alzeimer's disease by eating less salt/sodium and salty food.

Lose weight and benefit your health in countless other ways by eating less salt! - Go on! - Try it! - You will feel so much better! - How to Lose weight!

See my website http://www.wildeaboutsteroids.co.uk/ (The site does not sell anything and has no banners or sponsors or adverts - just helpful information.)

Read my Mensa article on Obesity and the Salt Connection

See Sodium in foods

Sunday, 13 May 2007

Pfizer, the pharmaceutical company, and the National Institute for Clinical Health and Excellence will face each other in court next month.

Have a Nice day? Pfizer in court clash with British drug authority - Independent on Sunday

Extract:

"The world's largest pharmaceutical company will next month square off with Nice, the government drug-rationing body, in an unprecedented showdown in the High Court.
The case, lodged by American drugs giant Pfizer and marketing partner Eisai of Japan, marks the first time that the Government's National Institute for Clinical Health and Excellence, the entity that recommends whether drugs should be reimbursed by the NHS, has been put in the dock.


It is the clearest sign yet of a growing clash between the pharmaceutical industry and the Government over the latter's efforts to reduce the £11bn that it spends every year on medicines.

"You could look at this as a line in the sand," said a Pfizer spokesman. "This goes beyond a purely financial or commercial objective. This is about Nice itself and how they operate."

The row stems from an initial decision by Nice in 2005 to withdraw approval for the NHS to buy a class of four drugs used to treat patients with Alzheimer's disease. One of the four was Aricept, which was developed by Eisai and is co-marketed by Pfizer. The move sparked a storm of controversy, forcing Nice to reconsider its position. Last year, it gave its final appraisal, which largely stuck to the first ruling.

However, it said in its latest ruling that those in the moderate phase of the disease, rather than in the early or very late stages, would qualify. That left most of the 700,000 dementia and Alzheimer's sufferers in the UK ineligible for NHS-funded treatment.

Nice's argument was that the drugs simply were not effective enough to give good "value for money". "

You can reduce your risk of developing Alzheimer's disease by cutting down on salt and salty food. - See http://www.wildeaboutsteroids.co.uk/socio.html